Literature DB >> 15277986

NK1.1 cells are required to control T cell hyperactivity during Trypanosoma cruzi infection.

Fabíola Cardillo1, Auro Nomizo, Edilberto Postól, José Mengel.   

Abstract

BACKGROUND: This study evaluated the regulatory function of NK1.1+ cells during Trypanosoma cruzi infection. MATERIAL/
METHODS: Both thymectomized (Tx C57Bl/6) and euthymic C57Bl/6 mice (C57Bl/6) were infected intraperitoneally with the Tulahuen strain. NK1.1+ cells were depleted in vivo by anti-NK1.1 mAb. Spleen cells were analyzed by flow cytometry for the expression of CD44 and CD69 on T cells. Supernatants from splenocytes were used to measure nitrite concentration (quantified by Griess reagent). Interleukin 2 and IFN-gamma levels were determined by ELISA. The protocols used herein were approved by the Institutional Committee for Ethics. Student's t or Kruskal-Wallis tests were applied, as indicated.
RESULTS: The number of T cells expressing CD69 increased progressively during T. cruzi infection in NK1.1 cell-depleted C57Bl/6 mice. In spite of an increased early T cell activation during infection, the percentage of CD4+ CD44high T cells did not augment in NK1.1 cell-depleted C57Bl/6 mice compared with untreated C57Bl/6 controls. Serum levels of IFN-gamma in anti-NK1.1-treated mice were higher than in non-depleted animals. Con-A-stimulated spleen cell supernatants from NK1.1 cell-depleted animals contained increased levels of IL-2 and nitric oxide (NO) during early infection.
CONCLUSIONS: After the first week of infection, NO overproduction and high levels of IFN-gamma in anti-NK1.1-tre-ated C57Bl/6 mice appeared to be related to susceptibility and hyperactivation of peripheral T cells. Finally, this study suggests a novel regulatory function of NK1.1+ cells during T. cruzi infection. Without NK1.1 cells, T lymphocytes are hyperactivated but do not differentiate to effector/memory T cells in infected C57Bl/6 mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15277986

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  5 in total

Review 1.  Immunity and immune modulation in Trypanosoma cruzi infection.

Authors:  Fabíola Cardillo; Rosa Teixeira de Pinho; Paulo Renato Zuquim Antas; José Mengel
Journal:  Pathog Dis       Date:  2015-10-04       Impact factor: 3.166

2.  Impairment in natural killer cells editing of immature dendritic cells by infection with a virulent Trypanosoma cruzi population.

Authors:  Estela I Batalla; Agustina M Pino Martínez; Carolina V Poncini; Tomás Duffy; Alejandro G Schijman; Stella M González Cappa; Catalina D Alba Soto
Journal:  J Innate Immun       Date:  2013-05-08       Impact factor: 7.349

3.  The Blockade of Interleukin-2 During the Acute Phase of Trypanosoma cruzi Infection Reveals Its Dominant Regulatory Role.

Authors:  Jorge Nihei; Fabiola Cardillo; Jose Mengel
Journal:  Front Cell Infect Microbiol       Date:  2021-11-17       Impact factor: 5.293

4.  C57BL/6 Mice Pretreated With Alpha-Tocopherol Show a Better Outcome of Trypanosoma cruzi Infection With Less Tissue Inflammation and Fibrosis.

Authors:  Amanda C O Silva; Maiara Bonfim; Jonathan L M Fontes; Washington L C Dos-Santos; José Mengel; Fabíola Cardillo
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

5.  The acute phase of Trypanosoma cruzi infection is attenuated in 5-lipoxygenase-deficient mice.

Authors:  Adriana M C Canavaci; Carlos A Sorgi; Vicente P Martins; Fabiana R Morais; Érika V G de Sousa; Bruno C Trindade; Fernando Q Cunha; Marcos A Rossi; David M Aronoff; Lúcia H Faccioli; Auro Nomizo
Journal:  Mediators Inflamm       Date:  2014-08-03       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.